Intermediate CAG repeats in huntington’s disease: Analysis of COHORT

Tremor and Other Hyperkinetic Movements

Volumn 2, Issue , 2012, Pages

  Ha, Ainhi D ^a   Beck, Christopher A ^b   Jankovic, Joseph ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Chorea; Genetic counseling; Huntingtin gene; Huntington disease; Intermediate repeats; Trinucleotide repeats

Indexed keywords

EID: 85114070290     PISSN: None     EISSN: 21608288     Source Type: Journal    
DOI: 10.5334/TOHM.85     Document Type: Article

References (20)

1. Ross CA, Tabrizi SJ. Huntington’s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 2011;10:83-98, http://dx.doi.org/10.1016/ S1474-4422(10)70245-3.
2. Herishanu YO, Parvari R, Pollack Y, et al. Huntington disease in subjects from an Israeli Karaite community carrying alleles of intermediate and expanded CAG repeats in the HTT gene: Huntington disease or phenocopy? J Neurol Sci 2009;277:143-146, http://dx.doi.org/10.1016/j.jns.2008.11.005.
3. Groen JL, de Bie RM, Foncke EM, et al. Late-onset Huntington disease with intermediate CAG repeats: true or false? J Neurol Neurosurg Psychiatry 2010; 81:228-230, http://dx.doi.org/10.1136/jnnp.2008.170902.
4. Andrich J, Arning L, Wieczorek S, et al. Huntington’s disease as caused by 34 CAG repeats. Mov Disord 2008;23:879-881, http://dx.doi.org/10.1002/ mds.21958.
5. Kenney C, Powell S, Jankovic J. Autopsy-proven Huntington’s disease with 29 trinucleotide repeats. Mov Disord 2007;22:127-130, http://dx.doi.org/10.1002/mds.21195.
6. Biglan K, Jankovic J, Eberly S, et al. Longitudinal analysis of intermediate CAGn repeat length expansion in the Prospective Huntington Disease At-Risk Observational Study (PHAROS). Mov Disord 2010(Suppl 2):S270.
7. Semaka A, Creighton S, Warby S, et al. Predictive testing for Huntington disease: interpretation and significance of intermediate alleles. Clin Genet 2006; 70:283-294, http://dx.doi.org/10.1111/j.1399-0004.2006.00668.x.
8. Cooperative Huntington’s Observational Research Trial. www. clinicaltrials.gov (accessed September 18, 2010).
9. Unified Huntington’s Disease Rating Scale: reliability and consistency. Huntington Study Group. Mov Disord 1996;11:136-142, http://dx.doi.org/10.1002/mds.870110204.
10. Rawlins M. Huntington’s disease out of the closet? Lancet 2010; 376(9750):1372-1373, http://dx.doi.org/10.1016/S0140-6736(10)60974-9.
11. Ha AD, Jankovic J. Exploring the correlates of intermediate CAG repeats in Huntington disease. Postgrad Med 2011;123:116-121, http://dx.doi. org/10.3810/pgm.2011.09.2466.
12. Squitieri F, Esmaeilzadeh M, Ciarmiello A, et al. Caudate glucose hypometabolism in a subject carrying an unstable allele of intermediate CAG(33) repeat length in the Huntington’s disease gene. Mov Disord 2011;26:925-927, http://dx.doi.org/10.1002/mds.23623.
13. Sequeiros J, Ramos EM, Cerqueira J, et al. Large normal and reduced penetrance alleles in Huntington disease: instability in families and frequency at the laboratory, at the clinic and in the population. Clin Genet 2010;78:381-387, http://dx.doi.org/10.1111/j.1399-0004.2010.01388.x.
14. Hendricks AE, Latourelle JC, Lunetta KL, et al. Estimating the probability of de novo HD cases from transmissions of expanded penetrant CAG alleles in the Huntington disease gene from male carriers of high normal alleles (27-35 CAG). Am J Med Genet A 2009;149A:1375-1381, http://dx.doi. org/10.1002/ajmg.a.32901.
15. Goldberg YP, McMurray CT, Zeisler J, et al. Increased instability of intermediate alleles in families with sporadic Huntington disease compared to similar sized intermediate alleles in the general population. Hum Mol Genet 1995;4:1911-1918, http://dx.doi.org/10.1093/hmg/4.10.1911.
16. Curtis A, Mitchell I, Patel S, et al. A pilot study using nabilone for symptomatic treatment in Huntington’s disease. Mov Disord 2009;24:2254-2259, http://dx.doi.org/10.1002/mds.22809.
17. Kieburtz K, McDermott MP, Voss TS, et al. A randomized, placebocontrolled trial of latrepirdine in Huntington disease. Arch Neurol 2010;67:154-160, http://dx.doi.org/10.1001/archneurol.2009.334.
18. Vaccarino AL, Anderson K, Borowsky B, et al. An item response analysis of the motor and behavioral subscales of the unified Huntington’s disease rating scale in huntington disease gene expansion carriers. Mov Disord 2011;26:877-884, http://dx.doi.org/10.1002/mds.23574.
19. Aziz NA, van der Burg JM, Landwehrmeyer GB, et al. Weight loss in Huntington disease increases with higher CAG repeat number. Neurology 2008; 71:1506-1513, http://dx.doi.org/10.1212/01.wnl.0000334276.09729.0e.
20. Patel S, Jankovic J, Hood A, et al. Reflexive and volitional saccades:Biomarkers of Huntington disease severity and progression. J Neurol Sci 2012 Feb 15;313(1-2):35-41.